Trials / Completed
CompletedNCT04382248
The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
Next Generation Self Management: The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 12 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical benefit of mobile app in combination with tailored coaching using text messaging to enhance patient activation, self-management and medication adherence and to determine whether immunological biomarkers such as cell-free DNA and donor specific antibodies are associated with self-management and medication adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Smartphone App | An app for monitoring medications, blood pressure, exercise, healthy eating |
| BEHAVIORAL | Tailored education | in-person coaching |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2021-08-31
- Completion
- 2021-11-30
- First posted
- 2020-05-11
- Last updated
- 2022-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04382248. Inclusion in this directory is not an endorsement.